ArticleTranslational oncology2024

TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts.

Shin Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.